Open: 3:22 PM
Novavax Stock Price Graph
Novavax Stock Price Today
Novavax, Inc. (NVAX) stock rallied over 0.18% intraday to trade at $5.57 a share on NASDAQ. The stock opened with a gain of 18.18% at $6.50 and touched an intraday high of $6.54, rising 1.27% against the last close of $5.50. The Novavax, Inc. in stock market went to a low of $6.30 during the session.
Novavax Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Novavax Stock Price History Chart
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Frequently Asked Questions
What is the current Novavax, Inc. (NVAX) stock price?
Novavax, Inc. (NASDAQ: NVAX) stock price is $5.57 in the last trading session. During the trading session, NVAX stock reached the peak price of $6.54 while $6.30 was the lowest point it dropped to. The percentage change in NVAX stock occurred in the recent session was 0.18% while the dollar amount for the price change in NVAX stock was $0.01.
NVAX's industry and sector of operation?
The NASDAQ listed NVAX is part of Biotechnology industry that operates in the broader Healthcare sector. Novavax, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs.
Who are the executives of NVAX?
Mr. Biegie Lee
Senior Vice President & Chief Information Officer
Mr. Troy Morgan Esq., J.D.
Senior Vice President & Chief Compliance Officer
Mr. John Charles Jacobs M.B.A.
Pres, Chief Executive Officer & Director
Mr. James Patrick Kelly C.F.A.
Executive Vice President, Chief Financial Officer & Treasurer
How NVAX did perform over past 52-week?
NVAX's closing price is 0.35% higher than its 52-week low of $5.61 where as its distance from 52-week high of $25.66 is -0.90%.
How many employees does NVAX have?
Number of NVAX employees currently stands at N/A. NVAX operates from 21 Firstfield Road, Gaithersburg, MD 20878, US.
Link for NVAX official website?
Official Website of NVAX is: https://www.novavax.com
How do I contact NVAX?
How many shares of NVAX are traded daily?
NVAX stock volume for the day was 6711128.00 shares. The average number of NVAX shares traded daily for last 3 months was 8.63 Million.
What is the market cap of NVAX currently?
The market value of NVAX currently stands at $661.66 Million with its latest stock price at $5.57 and N/A of its shares outstanding.